Cell Death Discovery · 2023 · 51 citations · 42 references
Life SciencesBiochemistryNutritional SciencesMetabolismMetabolomicsMolecular NeuroscienceGut MicrobiotaKetogenic Diet TherapyKetone Body MetabolismLipid MetabolismMass Spectrometry-based MetabolomicsTriglyceride MetabolismGut Microbiota CompositionMedium-chain Triglyceride DietMicrobiome-associated MetabolitesMicrobiota-derived MetabolitesNeuroprotective ResponsesNrf2 Pathway ActivationNrf2 Signaling PathwayParkinsonian Neuroprotection
The ketogenic diet (KD) is a low carbohydrate and high-fat protein diet. It plays a protective role in neurodegenerative diseases by elevating the levels of ketone bodies in blood, regulating central and peripheral metabolism and mitochondrial functions, inhibiting neuroinflammation and oxidative stress, and altering the gut microbiota. However, studies on ketogenic therapy for Parkinson's disease (PD) are still in their infancy. Therefore, we examined the possible protective effect of KD in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model, examined the mouse gut microbiota and its metabolites, and performed transcriptomics and metabolomics on the substantia nigra of mice. Our results showed that a long-term medium-chain triglyceride KD (MCT-KD) significantly reduced MPTP-induced damage to dopaminergic (DA) neurons, exerted antioxidant stress through the PI3K/Akt/Nrf2 pathway, and reversed oxidative stress in DA neurons. The MCT-KD also reduced mitochondrial loss, promoted ATP production, and inhibited the activation of microglia to protect DA neurons in MPTP-induced PD mice. MCT-KD altered the gut microbiota and consequently changed the metabolism of substantia nigra neurons through gut microbiota metabolites. Compared to the MPTP group, MCT-KD increased the abundance of gut microbiota, including Blautia and Romboutsia. MCT-KD also affects purine metabolism in the substantia nigra pars compacta (SNpc) by altering fecal metabolites. This study shows that MCT-KD has multiple protective effects against PD.
42
Diet rapidly and reproducibly alters the human gut microbiome
Lawrence A. David, Corinne F. Maurice, Rachel N. Carmody et al. · Nature · 2013 · 10.2K citations · Full text
Colonic bacterial composition in Parkinson's disease
Ali Keshavarzian, Stefan J. Green, Phillip A. Engen et al. · Movement Disorders · 2015 · 1.3K citations
Protocol for the MPTP mouse model of Parkinson's disease
Vernice Jackson‐Lewis, Serge Przedborski · Nature Protocols · 2007 · 1.1K citations
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet
C. Anders Olson, Helen E. Vuong, Jessica M. Yano et al. · Cell · 2018 · 1.1K citations